{"id":"epicept-np-1-cream","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"},{"rate":"5-10%","effect":"Pruritus"},{"rate":"5-10%","effect":"Application site reaction"}]},"_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the enzyme neutral endopeptidase (NEP), EpiCept-NP-1 Cream reduces the levels of substance P in the spinal cord, leading to a decrease in pain perception. This mechanism is thought to be responsible for its analgesic effects.","oneSentence":"EpiCept-NP-1 Cream is a topical analgesic that works by blocking the production of substance P, a neuropeptide involved in pain transmission.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:51:20.756Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe pain in patients with postherpetic neuralgia"}]},"trialDetails":[{"nctId":"NCT00471445","phase":"PHASE3","title":"Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients","status":"COMPLETED","sponsor":"Gary Morrow","startDate":"2007-10","conditions":"Neurotoxicity, Pain, Peripheral Neuropathy","enrollment":462},{"nctId":"NCT00475904","phase":"PHASE2","title":"A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)","status":"COMPLETED","sponsor":"EpiCept Corporation","startDate":"2007-07","conditions":"Post Herpetic Neuralgia, PHN, Neuropathy","enrollment":360},{"nctId":"NCT00476151","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"EpiCept Corporation","startDate":"2007-07","conditions":"Diabetic Peripheral Neuropathy, Neuralgia","enrollment":226}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21642,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"EpiCept-NP-1 Cream","genericName":"EpiCept-NP-1 Cream","companyName":"EpiCept Corporation","companyId":"epicept-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"EpiCept-NP-1 Cream is a topical analgesic that works by blocking the production of substance P, a neuropeptide involved in pain transmission. Used for Moderate to severe pain in patients with postherpetic neuralgia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}